Amneal Pharmaceuticals, Inc. AMRX Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s software and technology licenses, net?
- Amneal Pharmaceuticals, Inc. (AMRX) reported software and technology licenses, net of $54.88M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s software and technology licenses, net changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s software and technology licenses, net increased by 20.8% year-over-year, from $45.42M to $54.88M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s software and technology licenses, net has grown at a 20.9% compound annual growth rate (CAGR), from $22.34M to $57.81M.